
|Videos|March 21, 2017
Greater Competition and Specialty Drug Costs
Author(s)Lauren Santye, Assistant Editor
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.
Advertisement
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses whether increased competition for specialty drugs can lower costs.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5





































































































































































































